244 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
3 May 10
Entry into a Material Definitive Agreement
12:00am
discussed and agreed to a modified schedule for delivery of Targets and various other terms;
NOW THEREFORE, in consideration of the mutual covenants … or the completion of screening of all Targets selected by August 5, 2010.
The current version of Section 2.1.2 shall be deleted and replaced
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Oct 09
Entry into a Material Definitive Agreement
12:00am
.
In addition, under the amended agreement Ligand and GSK agreed to waive exclusivity on two biological targets, allowing both GSK and Ligand the freedom … to pursue independent research programs with such targets in addition to the current alliance programs. Furthermore, pursuant to the amended agreement
8-K
eghve
6 Feb 09
Entry into a Material Definitive Agreement
12:00am
8-K
wbnk7jckyt3xlemfon9
3 May 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.3
p3jx4eiob
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
n3h05chwzwp 3s7pyec
24 Jul 19
Other Events
12:00am
425
EX-99.3
n3k j96d9nc94ov
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
nqv29
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
ghcoae9eu5045l2zhu
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.1
w3n3k2y z9
12 Mar 19
Regulation FD Disclosure
10:02am
425
EX-99.2
eluqln 3xsq16l
25 Sep 08
Business combination disclosure
12:00am
8-K
unwes4e iz
1 Oct 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
ffzeckb4v4sray5ng6z9
4 Aug 09
Ligand and Organon Mutually Terminate Collaboration and License Agreement
12:00am
425
EX-99.2
kl28o zoo
10 Sep 09
Business combination disclosure
12:00am
8-K
EX-99.2
39o1u
10 Sep 09
Business Development and Strategic Planning
12:00am